Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ember Therapeutics (EMBT)
:EMBT
EMBT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.03 - $0.40
Previous CloseN/A
Volume200.00
Average Volume (3M)8.00
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)2.34K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.59
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding3,985,000
10 Day Avg. Volume23
30 Day Avg. Volume8
Standard Deviation1.15
R-Squared0.02
Alpha0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Ember Therapeutics News
---
EMBT FAQ
What was Ember Therapeutics ’s price range in the past 12 months?
Ember Therapeutics lowest stock price was $0.03 and its highest was $0.40 in the past 12 months.
What is Ember Therapeutics ’s market cap?
Currently, no data Available
When is Ember Therapeutics ’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Ember Therapeutics ’s earnings last quarter?
Currently, no data Available
Is Ember Therapeutics overvalued?
According to Wall Street analysts Ember Therapeutics ’s price is currently Overvalued.
Does Ember Therapeutics pay dividends?
Ember Therapeutics does not currently pay dividends.
What is Ember Therapeutics ’s EPS estimate?
Ember Therapeutics ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ember Therapeutics have?
Ember Therapeutics has 3,985,000 shares outstanding.
What happened to Ember Therapeutics ’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Ember Therapeutics ?
Currently, no hedge funds are holding shares in EMBT
---
Company Description
Ember Therapeutics
Ember Therapeutics Inc is engaged in the healthcare sector. It is a biopharmaceutical company whose primary focus is on utilizing Bone Morphogenetic Protein-7 (BMP-7) and related family of BMPs, mutants, variants, novel formulations, and delivery technologies. It looks to develop regenerative medicines for disease modification of osteoarthritis, reversal of insulin resistance, and the inhibition and reversal of organ fibrosis in diseases such as chronic kidney disease and Alport Syndrome.
---
Technical Analysis
---